This article is more than 5 years old. Information may no longer be current.
ISTO Technologies appoints new chief commercial officer
Click Here to Manage Email Alerts
ISTO Technologies Inc. appointed Phillip W. Kuhn, a medical technology executive with over three decades of industry experience, to the newly created position of Chief Commercial Officer.
“We are pleased to welcome Phil Kuhn, a strategic leader in the biologics space, to the ISTO team. Phil’s strong track record in developing new franchises and effective marketing programs while at Orthofix and Smith & Nephew has direct relevance to ISTO’s plan to build sales of InQu while developing new biologics products for orthopedic and spinal applications,” George Dunbar, President and Chief Executive Officer of ISTO, stated in a press release. “His hire will help raise ISTO’s profile among potential industry partners and is consistent with our goal to add relevant domain expertise that strengthens our ability to successfully execute our global strategy.”
Kuhn joins ISTO from Orthofix International N.V. where, as Vice President, Marketing, Orthopedics U.S., he led all U.S. and Canadian upstream and downstream product management, medical education, sales training and marketing communications, according to the release.